4934 Stock Overview Engages in the planning, development, import, export, mail order, wholesale, and retail of cosmetics and health foods in Japan. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add notePremier Anti-Aging Co., Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for Premier Anti-Aging Historical stock prices Current Share Price JP¥808.00 52 Week High JP¥1,095.00 52 Week Low JP¥641.00 Beta 0.77 1 Month Change -0.25% 3 Month Change 11.91% 1 Year Change -14.32% 3 Year Change -88.57% 5 Year Change n/a Change since IPO -84.64%
Recent News & Updates
Premier Anti-Aging Co., Ltd. to Report Q2, 2025 Results on Mar 13, 2025 Jan 03
First quarter 2025 earnings released: EPS: JP¥47.48 (vs JP¥4.01 loss in 1Q 2024) Dec 15
Premier Anti-Aging Co., Ltd. to Report Q1, 2025 Results on Dec 13, 2024 Oct 29
Premier Anti-Aging Co., Ltd. Announces Renewal of DUO the Cleansing Balm Series Oct 17
New major risk - Financial data availability Sep 17
Full year 2024 earnings: EPS and revenues exceed analyst expectations Sep 14 See more updates
Premier Anti-Aging Co., Ltd. to Report Q2, 2025 Results on Mar 13, 2025 Jan 03
First quarter 2025 earnings released: EPS: JP¥47.48 (vs JP¥4.01 loss in 1Q 2024) Dec 15
Premier Anti-Aging Co., Ltd. to Report Q1, 2025 Results on Dec 13, 2024 Oct 29
Premier Anti-Aging Co., Ltd. Announces Renewal of DUO the Cleansing Balm Series Oct 17
New major risk - Financial data availability Sep 17
Full year 2024 earnings: EPS and revenues exceed analyst expectations Sep 14
New minor risk - Share price stability Sep 12 Premier Anti-Aging Co., Ltd., Annual General Meeting, Oct 29, 2024
Little Excitement Around Premier Anti-Aging Co., Ltd.'s (TSE:4934) Revenues As Shares Take 30% Pounding Aug 06
New minor risk - Share price stability Aug 05
Premier Anti-Aging Co., Ltd. to Report Fiscal Year 2024 Results on Sep 12, 2024 Jul 06
Consensus EPS estimates upgraded to JP¥240 loss Jun 27
Third quarter 2024 earnings released: EPS: JP¥26.95 (vs JP¥14.56 loss in 3Q 2023) Jun 15
New minor risk - Share price stability Jun 14
Price target decreased by 28% to JP¥760 Apr 12
Consensus EPS estimates fall by 65% Apr 10
Premier Anti-Aging Co., Ltd. to Report Q3, 2024 Results on Jun 13, 2024 Apr 05
Second quarter 2024 earnings released: JP¥189 loss per share (vs JP¥19.72 profit in 2Q 2023) Mar 15
Premier Anti-Aging (TSE:4934) Has Debt But No Earnings; Should You Worry? Mar 04
Consensus EPS estimates fall by 10% Jan 11
Premier Anti-Aging Co., Ltd. to Report Q2, 2024 Results on Mar 14, 2024 Jan 06
First quarter 2024 earnings released: JP¥4.01 loss per share (vs JP¥22.71 loss in 1Q 2023) Dec 15
Full year 2023 earnings: EPS misses analyst expectations Nov 02
Premier Anti-Aging Co., Ltd. to Report Q1, 2024 Results on Dec 14, 2023 Oct 25
Full year 2023 earnings: EPS misses analyst expectations Sep 15
Premier Anti-Aging Co., Ltd. Provides Consolidated Earning Guidance for the Six Months Ending January 31, 2024 and Full Year Ending July 31, 2024 Sep 15
Premier Anti-Aging Co., Ltd., Annual General Meeting, Oct 27, 2023 Sep 14
New major risk - Share price stability Aug 15
Premier Anti-Aging Co., Ltd. to Report Fiscal Year 2023 Results on Sep 14, 2023 Jul 24
Third quarter 2023 earnings released: JP¥14.56 loss per share (vs JP¥15.83 loss in 3Q 2022) Jun 16
Premier Anti-Aging Co., Ltd. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending July 31, 2023 Jun 15
Now 21% undervalued after recent price drop Jun 15
Second quarter 2023 earnings released: EPS: JP¥19.72 (vs JP¥4.59 in 2Q 2022) Mar 15
Premier Anti-Aging Co., Ltd. (TSE:4934) completed the acquisition of Venex Co., Ltd from Taichi Nakamura and other shareholders. Feb 01
Premier Anti-Aging Co., Ltd. to Report Q2, 2023 Results on Mar 14, 2023 Jan 28
Premier Anti-Aging Co., Ltd. (TSE:4934) agreed to acquire Venex Co., Ltd from Taichi Nakamura and other shareholders. Jan 17
Price target decreased to JP¥1,880 Dec 22
Premier Anti-Aging Co., Ltd. Provides Earning Guidance for the Six Months Ending January 31, 2023 and Full Year Ending July 31, 2023 Dec 15
Premier Anti-Aging Co., Ltd. to Report Q1, 2023 Results on Dec 14, 2022 Oct 20
Investor sentiment deteriorated over the past week Sep 29
Consensus EPS estimates fall by 11% Sep 20 Premier Anti-Aging Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended January 31, 2023 and Fiscal Year Ended July 31, 2023
Now 21% undervalued after recent price drop Sep 12
Premier Wellness Science Co., Ltd. to Launch a New Brand "Reinca" Sep 07
Premier Wellness Science Co., Ltd. to Launch a New Brand "Reinca" Sep 06
Investor sentiment improved over the past week Sep 05
Premier Anti-Aging Co., Ltd. to Report Fiscal Year 2022 Results on Sep 13, 2022 Jul 28
Premier Anti-Aging Co., Ltd.’s Consolidated Subsidiary Premier Wellness Sciences Co., Ltd. Announces the Launch of Its New Brand "Ko" with CBD Jul 07
Consensus forecasts updated Jun 14
Investor sentiment deteriorated over the past week Jun 14
Premier Anti-Aging Co., Ltd. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending July 31, 2022 Jun 13
Price target decreased to JP¥5,060 Apr 27
Premier Anti-Aging Co., Ltd. to Report Q3, 2022 Results on Jun 13, 2022 Apr 22
Investor sentiment improved over the past week Apr 04
Consensus EPS estimates fall by 11% Mar 21
Investor sentiment deteriorated over the past week Mar 09
Premier Anti-Aging Co., Ltd. to Report Q2, 2022 Results on Mar 14, 2022 Jan 28
Price target decreased to JP¥14,330 Dec 16
Investor sentiment improved over the past week May 20
Investor sentiment improved over the past week Apr 02
Investor sentiment improved over the past week Mar 17
New 90-day high: JP¥9,410 Mar 16
Premier Anti-Aging Co., Ltd. to Report Q2, 2021 Results on Mar 15, 2021 Jan 07
Premier Anti-Aging Co., Ltd. to Report Q1, 2021 Results on Dec 14, 2020 Nov 08
Premier Anti-Aging Co., Ltd. has completed an IPO in the amount of ¥9.729 billion. Oct 29 Shareholder Returns 4934 JP Personal Products JP Market 7D 0.6% 2.0% 1.4% 1Y -14.3% -12.4% 7.4%
See full shareholder returns
Return vs Market: 4934 underperformed the JP Market which returned 7.4% over the past year.
Price Volatility Is 4934's price volatile compared to industry and market? 4934 volatility 4934 Average Weekly Movement 7.2% Personal Products Industry Average Movement 3.6% Market Average Movement 3.5% 10% most volatile stocks in JP Market 7.4% 10% least volatile stocks in JP Market 1.8%
Stable Share Price: 4934's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 4934's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company Premier Anti-Aging Co., Ltd. engages in the planning, development, import, export, mail order, wholesale, and retail of cosmetics and health foods in Japan. It offers its products under the DUO, CANADEL, Immuno, Sitrana, and Clayence brands. The company was incorporated in 2009 and is headquartered in Tokyo, Japan.
Show more Premier Anti-Aging Co., Ltd. Fundamentals Summary How do Premier Anti-Aging's earnings and revenue compare to its market cap? 4934 fundamental statistics Market cap JP¥7.05b Earnings (TTM ) -JP¥1.03b Revenue (TTM ) JP¥19.33b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 4934 income statement (TTM ) Revenue JP¥19.33b Cost of Revenue JP¥4.00b Gross Profit JP¥15.33b Other Expenses JP¥16.36b Earnings -JP¥1.03b
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
Mar 13, 2025
Earnings per share (EPS) -118.57 Gross Margin 79.32% Net Profit Margin -5.35% Debt/Equity Ratio 31.4%
How did 4934 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/30 01:07 End of Day Share Price 2025/01/30 00:00 Earnings 2024/10/31 Annual Earnings 2024/07/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Premier Anti-Aging Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Katsuro Hirozumi Daiwa Securities Co. Ltd. null null Storm Research Limited
Show 0 more analysts